Related Experiment Video
Updated: Jun 27, 2026

06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Attitudes toward postmenopausal long-term hormone therapy.
Petra Kolip1, Nicole Hoefling-Engels, Norbert Schmacke
1University of Bremen, Bremen, Germany.
Qualitative Health Research
|December 4, 2008
Summary
Postmenopausal hormone therapy use varies among women, driven by diverse attitudes and expectations. Understanding these individual profiles is key for effective patient counseling regarding hormone replacement therapy.
Area of Science:
- Gynecology
- Sociology of Health
- Psychology
Background:
- Menopause is a natural biological transition for women.
- Postmenopausal hormone therapy (HT) is a common medical intervention.
- Understanding women's motivations for HT is crucial for personalized care.
Purpose of the Study:
- To explore the reasons why postmenopausal women use hormone therapy.
- To identify different user profiles based on motivations and expectations.
- To inform the development of targeted counseling strategies for HT.
Main Methods:
- Qualitative study involving 35 postmenopausal women (aged 46-75) in Bremen, Germany.
- Interviews conducted with women using postmenopausal hormones for at least 12 months.
- Analysis of interview data using Fritz Schütze's reconstructive analytical procedure.
Main Results:
- Five distinct user types were identified based on their reasons for and expectations of hormone therapy.
- User types exhibited varying personal habits, circumstances, and attitudes (e.g., integrity-preserving, performance-oriented, searching, faith-in-medicine, benefit-generalizing).
- Significant differences were observed in motivations and expectations among the identified user groups.
Conclusions:
- Postmenopausal hormone therapy use is influenced by a complex interplay of individual attitudes and life circumstances.
- A one-size-fits-all approach to HT counseling is insufficient.
- Tailored counseling that addresses individual attitudes toward menopause and hormone therapy is essential for optimal patient outcomes and informed decision-making.
Related Concept Videos
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...